List of insiders holdings for VYNE Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| AI Biotechnology LLC Access Industries Holdings LLC ACCESS INDUSTRIES MANAGEMENT LLC Blavatnik Len 10% Owner | 2023-11-13 08:30:21 | 8,909,033 0 | 8,909,033 | Form 3 |
| Vivo Capital VIII LLC Vivo Capital Surplus Fund VIII L.P. Vivo Capital Fund VIII L.P. 10% Owner | 2020-06-11 17:09:43 | 3,643,824 0 | 3,643,824 | Form 13G |
| Remeditex Ventures LLC 10% Owner | 2018-01-29 16:19:55 | 2,761,663 0 | 2,761,663 | Form 4 |
| PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 2022-02-14 19:33:57 | 2,425,604 0 | 2,425,604 | Form 13G |
| Hadar Ilan CFO and Country Manager | 2020-03-11 17:56:34 | 546,910 0 | 546,910 | Form 4 |
| Hirsch Stanley Director | 2020-04-07 17:22:35 | 201,410 328,609 | 530,019 | Form 4 |
| Domzalski David PRESIDENT AND CEO | 2024-10-02 16:15:08 | 496,696 0 | 496,696 | Form 4 |
| Cha Albert Director | 2018-01-29 16:14:57 | 0 486,695 | 486,695 | Form 4 |
| Presidio Partners 2007 GP L.P. Presidio Partners 2007 (Parallel) L.P. Presidio Partners 2007 L.P. Collier David J Watson James F Sohail Faysal A. Former 10% Owner | 2018-07-26 19:11:02 | 0 200,972 | 200,972 | Form 4 |
| Harsch Mutya CHIEF LEGAL OFFICER AND GC | 2024-10-02 16:15:07 | 149,026 0 | 149,026 | Form 4 |
| Whitcup Scott M Director | 2019-08-08 21:17:23 | 134,099 0 | 134,099 | Form 4/A |
| Stuart Iain CHIEF SCIENTIFIC OFFICER | 2024-10-02 16:15:11 | 133,494 0 | 133,494 | Form 4 |
| Zeronda Tyler CHIEF FINANCIAL OFFICER | 2024-10-02 16:15:16 | 131,567 0 | 131,567 | Form 4 |
| Saik Andrew Chief Financial Officer | 2021-06-02 16:31:40 | 116,468 0 | 116,468 | Form 4 |
| Wiley Matthew T. Chief Commercial Officer | 2021-07-02 16:36:53 | 109,246 0 | 109,246 | Form 4 |
| Spellman Mary Chief Medical Officer | 2018-12-12 18:43:44 | 96,000 0 | 96,000 | Form 4 |
| MCGIRR DAVID W J Director | 2019-08-08 21:17:22 | 65,780 0 | 65,780 | Form 4/A |
| BERNS PAUL L Director | 2019-08-08 21:18:55 | 65,780 0 | 65,780 | Form 4/A |
| Ebel Ted Director | 2019-08-08 21:39:57 | 53,423 0 | 53,423 | Form 4/A |
| Kwon Paul Chief Scientific Officer | 2019-12-16 17:13:19 | 52,534 0 | 52,534 | Form 4/A |
| BALL KRISTINE M See Remarks | 2019-12-16 17:14:49 | 52,534 0 | 52,534 | Form 4/A |
| Borowski Christine Director | 2024-01-03 17:07:13 | 40,000 0 | 40,000 | Form 4 |
| Royston Aaron Director | 2019-08-08 21:24:22 | 22,500 0 | 22,500 | Form 4/A |
| Bright Rex Director | 2021-07-20 17:05:03 | 20,500 0 | 20,500 | Form 4 |
| BARBARI SHARON Director | 2024-01-03 17:09:19 | 20,000 0 | 20,000 | Form 4 |
| Basta Steven L Director | 2024-01-03 17:10:38 | 20,000 0 | 20,000 | Form 4 |
| Bruno Anthony D Director | 2024-01-03 17:11:50 | 20,000 0 | 20,000 | Form 4 |
| LEPORE PATRICK G Director | 2024-01-03 17:13:09 | 20,000 0 | 20,000 | Form 4 |
| Sandoval Elisabeth Director | 2024-01-03 17:14:22 | 20,000 0 | 20,000 | Form 4 |
| Krasnow Ronald A. See Remarks | 2019-12-13 21:58:18 | 15,819 0 | 15,819 | Form 4 |
| FMR LLC See Remark 1 | 2019-02-13 11:58:21 | 333 0 | 333 | Form 13G |
| venBio Global Strategic Fund II L.P. 10% Owner | 2020-04-16 12:47:05 | 0 0 | 0 | Form 13D |
| Merck & Co. Inc. Merck Sharp & Dohme Corp. 10% Owner | 2019-02-14 14:09:26 | 0 0 | 0 | Form 13G |